Financials

News Ideas Discussions Technicals Forecast Seasonals Options

KRYS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Krystal Biotech, Inc.

Total assets of KRYS for Q1 25 is 1.07 B USD, 1.76% more than the previous Q4 24. And total liabilities decreased by 18.01% in Q1 25 to 89.74 M USD.

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD